GlassScriptPhysician profile
James W Bogener
NPI 1669417416
$5,976.49
in general payments reported to CMS, 2019-2025
9 companies · $1,115 in 2025
The $1,115 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $800 · 2021: $640 · 2022: $1,608 · 2024: $1,813 · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Travel and Lodging: $726 · Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $725.94 |
| Food and Beverage | $402.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $2,907.20 | 2022-2024 | |
| Treace Medical Concepts, INC. | $918.87 | 2021-2025 | |
| Stryker Corporation | $832.38 | 2021-2025 | Prostep Mica |
| Kci USA, INC. | $800.00 | 2020 | |
| Medwest Associates | $294.00 | 2022 | |
| Medartis INC. | $119.58 | 2025 | Aptus |
| Paragon 28, INC. | $45.63 | 2025 | Apex 3d |
| Lightbody Medical Technologies INC | $29.52 | 2025 | |
| Smith+Nephew, INC. | $29.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bogener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.